Finally, CBX treatment had no toxic effect on leukemic BM-MSCs since it did not induce apoptosis in primary BM-MSCs isolated from AML patients (Supplementary Fig. S5d). The gene discussed is CBX1; the disease is acute myeloid leukemia.